A surveillance study of antimicrobial resistance of Gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 3, 1999, Pages 373-378

  Günseren, Filiz ^b   Mamikoǧlu, Latife ^b   Öztürk, Süheyla ^b   Yücesoy, Mine ^b   Biberoǧlu, Kadir ^b   Yuluǧ, Nuran ^b   Doǧanay, Mehmet ^b   Sümerkan, Bülent ^b   Kocagöz, Sesin ^b   Ünal, Serhat ^b   Çetin, Sila ^b   Çalangu, Semra ^a   Köksal, Iftihar ^b   Leblebicioǧlu, Hakan ^b   Günaydin, Murat ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFEPIME; CEFODIZIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; INTENSIVE CARE; KLEBSIELLA; NONHUMAN; PSEUDOMONAS; RESPIRATORY TRACT INFECTION; TURKEY (REPUBLIC); URINARY TRACT INFECTION;

EID: 0345291178     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.3.373     Document Type: Article

References (17)

1. Vincent, J. L., Bihari, D. J., Suter, P. M., Bruining, H. A., White, J., Nicolas-Chanoin, M. H. et al. (1995). The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 274, 639-44.
2. Vaqué, J., Rossello, J., Trilla, A., Monge, V., Garcia-Caballero, J., Arribas, J. L. et al. (1996). Nosocomial infections in Spain: results of five nationwide serial prevalance surveys (EPINE project, 1990 to 1994). Infection Control and Hospital Epidemiology 17, 293-7.
3. Gould, I. M. (1994). Risk factors for acquisition of multiply drug-resistant Gram-negative bacteria. European Journal of Clinical Microbiology and Infectious Diseases 13, Suppl. 1, 30-8.
4. Flaherty, J. P. & Weinstein, R. A. (1996). Nosocomial infection caused by antibiotic-resistant organisms in the intensive care unit. Infection Control and Hospital Epidemiology 17, 236-48.
5. Verbist, L. (1993). Epidemiology and sensitivity of 8625 ICU and haematology/oncology bacterial isolates in Europe. Scandinavian Journal of Infectious Diseases Suppl. 91, 14-24.
6. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically - Third Edition: Approved Standard M-7A3. NCCLS, Villanova, PA.
7. Livermore, D. M. & Yuan, M (1996). Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. Journal of Antimicrobial Chemotherapy 38, 409-24.
8. Shah, P. M., Asanger, R. & Kahan, F. M. (1991). Incidence of multi-resistance in Gram-negative aerobes from intensive care units of 10 German hospitals. Scandinavian Journal of Infectious Diseases Suppl. 78, 22-34.
9. Snydman, D. R. (1991). Clinical implications of multi-drug resistance in the intensive care unit. Scandinavian Journal of Infectious Diseases Suppl. 78, 54-63.
10. Livermore, D. M. (1995). β-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8, 557-84.
11. Duval, J., Soussy, C. J., Acar, J. F., Bergogne-Bérézin, E., Cluzel, R., Thabaut, A. et al. (1993). In vitro antibacterial activity of cefepime: a multicentre study. Journal of Antimicrobial Chemotherapy 32, Suppl. B, 55-61.
12. Sirot, D. (1995). Extended-spectrum plasmid-mediated β-lactamases. Journal of Antimicrobial Chemotherapy 36, Suppl. A, 19-34.
13. Gutmann, L., Kitzis, M. D., Billot-Klein, D., Goldstein, F., Tran Van Nhieu, G., Lu, T. et al. (1988). Plasmid mediated β-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Reviews of Infectious Diseases 10, 860-6.
14. Vahaboǧlu, H., Hall, L. M. C., Mülazimoǧlu, L., Dodanli, S., Yildirim, I. & Livermore, D. M. (1995). Resistance to extended-spectrum cephalosporins, caused by PER-1 β-lactamase in Salmonella typhimurium from Istanbul, Turkey. Journal of Medical Microbiology 43, 294-9.
15. Danel, F., Hall, L. M. C., Gür, D., Akalin, H. E. & Livermore, D. M. (1995). Transferable production of PER-1 β-lactamase in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 35, 281-94.
16. Jacoby, G. A. & Medeiros, A. A. (1991). More extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 35, 1697-704.
17. Livingstone, D., Gill, M. J. & Wise, R. (1995). Mechanisms of resistance to the carbapenems. Journal of Antimicrobial Chemotherapy 35, 1-5.